The report will be delivered in 2-3 business days.

Convalescent Plasma Therapy Global Market Report 2021: COVID-19 Implications And Growth To 2030

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7559 | Format :


The convalescent plasma therapy market consists of sales of convalescent plasma obtained from patients who have recovered from an infection. Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism. The revenue generated by the market includes the sales of convalescent plasma collected from people post-infection, which will be utilized for prophylaxis and treatment of infected patients with the respective microorganism. The companies engaged in the convalescent plasma market are primarily engaged in the collection and processing of convalesced plasma for the utilization by research institutes, laboratories, hospitals and clinics.

The convalescent plasma therapy market covered in this report is segmented by application into prophylaxis, treatment. The convalescent plasma therapy market is also segmented by end-users into hospitals & clinics, laboratories & research institutes and by antibody type into IgM, IgG, IgA.

The global convalescent plasma therapy market is expected to grow from $0.026 billion in 2020 to $0.028 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The convalescent plasma therapy market is expected to reach $0.05 billion in 2025 at a CAGR of 16%.

Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2020, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS-CoV-2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost market growth.

The availability of scant evidence regarding the safety and efficacy of convalescent plasma therapy led to strict guidelines by government authorities. Different government authorities like the US FDA, CDSCO of India and others have approved COVID-19 convalescent plasma for investigational use only and not for prescribed indication. In May 2020, FDA released guidelines for COVID-19 convalescent plasma therapy, which stated that the administration of COVID-19 convalescent plasma must be under the investigational new drug application (IND) for clinical trials, expanded access and single-patient emergency only. Even for a single patient emergency, an eIND must be filed with FDA for the use of convalescent plasma therapy, provided, the health care provider must determine that the probable risk from the investigational drug is not greater than the probable risk from the disease or condition. COVID-19 convalescent plasma should be obtained from an FDA-registered blood establishment that follows the donor eligibility criteria and donor qualifications. The manufacturing process and shelf life should be the same as that of other similar plasma products. These strict guidelines framed by authorities are expected to limit the market growth.

The development of antibody-based immunotherapy as a potential therapeutic intervention for COVID-19 shows opportunities for the convalescent plasma therapy market. Convalescent plasma therapy utilizes the antibodies produced against coronavirus by the donor to improve the immunity of the recipient. Companies are initiating trials, collaborating and investing for antibody-based COVID-19 therapy. In April 2020, GSK entered into a collaboration with Vir Biotechnology and invested $250 million in Vir to support the development of anti-viral antibody-based solutions against novel coronavirus. In April 2020, Biomedical Advanced Research Development Authority (BARDA) partnered with Emergent BioSolutions to fund $14.5 million to support the development of human plasma-derived therapy which is COVID-Human Immune Globulin (COVID-HIG) for treating COVID-19 in severe hospitalized and high-risk patients. In April 2020, global plasma companies like CSL Behring, Takeda Pharmaceutical Company Limited, Biotest, BPL, LFB, and Octapharma collaborated to develop plasma-derived COVID-19 Hyperimmune Therapy. As convalescent plasma therapy utilizes antibodies, the focus over antibody-based COVID-19 therapy is expected to boost the market growth.

In March 2020, Grifols, a Spain-based multinational pharmaceutical and chemical manufacturer that develops, produces, and markets innovative solutions under divisions - Bioscience, Diagnostic, Hospital and Bio Supplies, announced its collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies. Under this collaboration, Grifols will collect plasma from FDA approved plasma collection centers to develop a hyperimmune globulin as a treatment option for COVID-19 patients and will support the convalescent plasma therapy approach by providing inactivated plasma for transfusion using viral inactivation technology (methylene blue). FDA is a federal agency and BARDA is an authority of the United States Department of Health and Human Services that protects public health through the transition of medical products like vaccines, biopharmaceuticals, pharmaceuticals, and others from research to FDA approval for the public use.

Major players in the convalescent plasma therapy market are Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited, and Orthosera Kft.

The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the convalescent plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global convalescent plasma therapy market is segmented -

1) By Application: Prophylaxis, Treatment

2) By End-Users: Hospitals & Clinics, Laboratories & Research Institutes

3) By Antibody Type: IgM, IgG, IgA

    Table Of Contents

    1. Executive Summary

    2. Convalescent Plasma Therapy Market Characteristics

    3. Convalescent Plasma Therapy Market Trends And Strategies

    4. Impact Of COVID-19 On Convalescent Plasma Therapy

    5. Convalescent Plasma Therapy Market Size And Growth

    5.1. Global Convalescent Plasma Therapy Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Convalescent Plasma Therapy Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Convalescent Plasma Therapy Market Segmentation

    6.1. Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Prophylaxis

    Treatment

    6.2. Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospitals & Clinics

    Laboratories & Research institutes

    6.3. Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    IgM

    IgG

    IgA

    7. Convalescent Plasma Therapy Market Regional And Country Analysis

    7.1. Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Convalescent Plasma Therapy Market

    8.1. Asia-Pacific Convalescent Plasma Therapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Convalescent Plasma Therapy Market

    9.1. China Convalescent Plasma Therapy Market Overview

    9.2. China Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Convalescent Plasma Therapy Market

    10.1. India Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Convalescent Plasma Therapy Market

    11.1. Japan Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Convalescent Plasma Therapy Market

    12.1. Australia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Convalescent Plasma Therapy Market

    13.1. Indonesia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Convalescent Plasma Therapy Market

    14.1. South Korea Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Convalescent Plasma Therapy Market

    15.1. Western Europe Convalescent Plasma Therapy Market Overview

    15.2. Western Europe Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Convalescent Plasma Therapy Market

    16.1. UK Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Convalescent Plasma Therapy Market

    17.1. Germany Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Convalescent Plasma Therapy Market

    18.4. France Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Convalescent Plasma Therapy Market

    19.1. Eastern Europe Convalescent Plasma Therapy Market Overview

    19.2. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Convalescent Plasma Therapy Market

    20.1. Russia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Convalescent Plasma Therapy Market

    21.1. North America Convalescent Plasma Therapy Market Overview

    21.2. North America Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Convalescent Plasma Therapy Market

    22.1. USA Convalescent Plasma Therapy Market Overview

    22.2. USA Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Convalescent Plasma Therapy Market

    23.1. South America Convalescent Plasma Therapy Market Overview

    23.2. South America Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Convalescent Plasma Therapy Market

    24.1. Brazil Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Convalescent Plasma Therapy Market

    25.1. Middle East Convalescent Plasma Therapy Market Overview

    25.2. Middle East Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Convalescent Plasma Therapy Market

    26.1. Africa Convalescent Plasma Therapy Market Overview

    26.2. Africa Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Convalescent Plasma Therapy Market Competitive Landscape And Company Profiles

    27.1. Convalescent Plasma Therapy Market Competitive Landscape

    27.2. Convalescent Plasma Therapy Market Company Profiles

    27.2.1. Bio Farma

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Grifols

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Hilton Pharma

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Biotest

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. BPL

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Market

    29. Convalescent Plasma Therapy Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Bio Farma Financial Performance
  • Table 47: Grifols Financial Performance
  • Table 48: Hilton Pharma Financial Performance
  • Table 49: Biotest Financial Performance
  • Table 50: BPL Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Bio Farma Financial Performance
  • Figure 47: Grifols Financial Performance
  • Figure 48: Hilton Pharma Financial Performance
  • Figure 49: Biotest Financial Performance
  • Figure 50: BPL Financial Performance
Global Medication Adherence Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Metabolomics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Soft Tissue Repair Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medical Tourism Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Mycoplasma Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pyrogen Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Antimicrobial Susceptibility Testing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medical Billing Outsourcing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilar Lymphocyte Modulator Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Filgrastim Biosimilars Market - By Application (Oncology, Chronic and Autoimmune Diseases, Blood disorders, Growth hormone deficiency, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), And By Region, Opportunities And Strategies – Global Filgrastim Biosimilars Market Forecast To 2030
View Report
Pegfilgrastim Biosimilars Market - By Application (Chemotherapy Induced Neutropenia, Transplantation, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order/Online Pharmacies), And By Region, Opportunities And Strategies – Global Pegfilgrastim Biosimilars Market Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)